Category: Psoriasis
Psoriasis market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Interleukin Blockers for Psoriasis Treatments
The 2025-2030 World Outlook for Interleukin Blockers for Psoriasis Treatments This study covers the world outlook for interleukin blockers for psoriasis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Psoriasis Medicines
The 2025-2030 World Outlook for Psoriasis Medicines This study covers the world outlook for psoriasis medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Psoriatic Arthritis Treatments
The 2025-2030 World Outlook for Psoriatic Arthritis Treatments This study covers the world outlook for psoriatic arthritis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Psoriasis Treatments
The 2025-2030 World Outlook for Psoriasis Treatments This study covers the world outlook for psoriasis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Psoriasis Drugs
The 2025-2030 World Outlook for Psoriasis Drugs This study covers the world outlook for psoriasis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Systemic Psoriasis Biologics
The 2025-2030 World Outlook for Systemic Psoriasis Biologics This study covers the world outlook for systemic psoriasis biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Tumor Necrosis Factor Inhibitors for Psoriasis Drugs
The 2025-2030 World Outlook for Tumor Necrosis Factor Inhibitors for Psoriasis Drugs This study covers the world outlook for tumor necrosis factor inhibitors for psoriasis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry e ... Read More
-
The 2025-2030 World Outlook for Systemic Psoriasis Therapeutics
The 2025-2030 World Outlook for Systemic Psoriasis Therapeutics This study covers the world outlook for systemic psoriasis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
Research Assistance
